Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytori Therapeutics Inc (NASDAQ:CYTX)

0.315
Delayed Data
As of Aug 28
 +0.0157 / +5.25%
Today’s Change
0.28
Today|||52-Week Range
1.47
-35.54%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$52.3M

Company Description

Cytori Therapeutics, Inc. is a late stage cell therapy company. Its develops autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally by improving blood flow, modulating the immune system, and facilitating wound repair. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in San Diego, CA.

Contact Information

Cytori Therapeutics, Inc.
3020 Callan Road
San Diego California 92121
P:(858) 458-0900
Investor Relations:

Employees

Shareholders

Individual stakeholders9.39%
Mutual fund holders4.98%
Other institutional13.60%

Top Executives

Marc H. HedrickPresident, Chief Executive Officer & Director
Tiago GirĂŁoCFO, Vice President & Head-Investor Relations
Steven KestenChief Medical Officer & Executive Vice President
John K. FraserChief Scientist
Seijiro Norio ShirahamaPresident-Asia Pacific Region